Ivabradine for treating chronic heart failure

Review proposal paper (PDF 284 KB)

Stakeholder matrix (PDF 256 KB)

TA267 Chronic heart failure - ivabradine: press release information

Chronic heart failure - ivabradine: equality impact assessment - scoping (PDF 63 KB)

Heart failure (chronic) - ivabradine: EIA - guidance development (PDF 78 KB)

Heart failure (chronic) - ivabradine: final appraisal determination information

Heart failure (chronic) - ivabradine: final appraisal determination (PDF 314 KB)

Heart failure (chronic) - ivabradine: response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD) (PDF 281 KB)

Heart failure (chronic) - ivabradine: consultee and commentator comments on the ACD

Heart failure (chronic) - ivabradine: Servier (PDF 222 KB)

Heart failure (chronic) - ivabradine: British Society for Heart Failure (PDF 55 KB)

Heart failure (chronic) - ivabradine: NHS Devon (PDF 102 KB)

Heart failure (chronic) - ivabradine: Commissioning Support Appraisals Service (PDF 281 KB)

Heart failure (chronic) - ivabradine: BMJ Group (PDF 96 KB)

Heart failure (chronic) - ivabradine: National Clinical Guideline Centre (PDF 8.6 KB)

Heart failure (chronic) - ivabradine: Cowie (PDF 178 KB)

Heart failure (chronic) - ivabradine: comments on the ACD received from the public through the NICE website (PDF 40 KB)

Heart failure (chronic) - ivabradine: appraisal consultation

Heart failure (chronic) - ivabradine: appraisal consultation document information

Heart failure (chronic) - ivabradine: Evaluation report

Heart failure (chronic) - ivabradine: Pre-meeting briefing (PDF 479 KB)

Heart failure (chronic) - ivabradine: Evidence Review Group report (PDF 2.04 MB)

Heart failure (chronic) - ivabradine: Erratum to the Evidence Review Group report (PDF 257 KB)

Heart failure (chronic) - ivabradine: Evidence Review Group report - factual accuracy check (PDF 197 KB)

Heart failure (chronic) - ivabradine: Servier Laboratories Ltd. (PDF 3.31 MB)

Clarification

Heart failure (chronic) - ivabradine: NICE clarification letter (PDF 181 KB)

Heart failure (chronic) - ivabradine: Manufacturer response to the NICE clarification letter (PDF 1.2 MB)

Patient group, professional group and NHS organisation submission statements

Heart failure (chronic) - ivabradine: South Asian Health Foundation (PDF 74 KB)

Heart failure (chronic) - ivabradine: British Association for Nursing in Cardiovascular Care (PDF 54 KB)

Expert written personal statements

Heart failure (chronic) - ivabradine: Clarke (PDF 80 KB)

Heart failure (chronic) - ivabradine: Cowie (PDF 80 KB)

Heart failure (chronic) - ivabradine: Hardman (PDF 115 KB)

Heart failure (chronic) - ivabradine: Williams (PDF 87 KB)

Heart failure (chronic) - ivabradine: Teague (PDF 52 KB)

Heart failure (chronic) - ivabradine: response to consultee and commentator comments on the draft scope and provisional matrix (PDF 202 KB)

Heart failure (chronic) - ivabradine: final scope (PDF 52 KB)

Heart failure (chronic) - ivabradine: final matrix (PDF 64 KB)

Heart failure (chronic) - ivabradine: appendix B - draft scope for consultation (pre-referral) - May 2011 (PDF 57 KB)

Heart failure (chronic) - ivabradine: appendix C - provisional matrix (pre-referral) - May 2011 (PDF 60 KB)